TY - JOUR
T1 - Feasibility and potential benefit of pre-procedural CMR imaging in patients with ischaemic cardiomyopathy undergoing cardiac resynchronisation therapy
AU - Gathier, W. A.
AU - Salden, O. A.E.
AU - van Ginkel, D. J.
AU - van Everdingen, W. M.
AU - Mohamed Hoesein, F. A.A.
AU - Cramer, M. J.M.
AU - Doevendans, P. A.
AU - Meine, M.
AU - Chamuleau, S. A.J.
AU - van Slochteren, F. J.
N1 - Funding Information:
W.A. Gathier, P.A. Doevendans and S.A.J. Chamuleau report grants from CVON: The Dutch Heart Foundation, Dutch Federations of University Medical Centres, the Netherlands Organisation for Health Research and Development, and the Royal Netherlands Academy of Sciences. F.J. van Slochteren is Chief Technology Officer and co-founder of CART-Tech, a spin-out of the Division of Heart and Lungs of the University Medical Centre in Utrecht focusing on imaging support for CRT placement. S.A.J. Chamuleau is co-founder of CART-Tech. O.A.E. Salden, D.J. van Ginkel, W.M. van Everdingen, F.A.A. Mohamed Hoesein, M.J.M. Cramer and M. Meine declare that they have no competing interests.
Funding Information:
This work was supported by grants from the Netherlands CardioVascular Research Initiative (CVON) (grant number: CVON2011-12): The Dutch Heart Foundation, Dutch Federations of University Medical Centres, the Netherlands Organisation for Health Research and Development, and the Royal Netherlands Academy of Sciences.
Funding Information:
This work was supported by grants from the Netherlands CardioVascular Research Initiative (CVON) (grant number: CVON2011-12): The Dutch Heart Foundation, Dutch Federations of University Medical Centres, the Netherlands Organisation for Health Research and Development, and the Royal Netherlands Academy of Sciences.
Publisher Copyright:
© 2019, The Author(s).
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Aim: To determine the feasibility and potential benefit of a full cardiac magnetic resonance (CMR) work-up for assessing the location of scarred myocardium and the region of latest contraction (LCR) in patients with ischaemic cardiomyopathy (ICM) undergoing cardiac resynchronisation therapy (CRT). Methods: In 30 patients, scar identification and contraction timing analysis was retrospectively performed on CMR images. Fluoroscopic left ventricular (LV) lead positions were scored with respect to scar location, and when placed outside scar, with respect to the LCR. The association between the lead position with respect to scar, the LCR and echocardiographic LV end-systolic volume (LVESV) reduction was subsequently evaluated. Results: The CMR work-up was feasible in all but one patient, in whom image quality was poor. Scar and contraction timing data were succesfully displayed on 36-segment cardiac bullseye plots. Patients with leads placed outside scar had larger LVESV reduction (−21 ± 21%, n = 19) compared to patients with leads within scar (1 ± 25%, n = 11), yet total scar burden was higher in the latter group. There was a trend towards larger LVESV reduction in patients with leads in the scar-free LCR, compared to leads situated in scar-free segments but not in the LCR (−34 ± 14% vs −15 ± 21%, p = 0.06). Conclusions: The degree of reverse remodelling was larger in patients with leads situated in a scar-free LCR. In patients with leads situated within scar there was a neutral effect on reverse remodelling, which can be caused both by higher scar burden or lead position. These findings demonstrate the feasibility of a CMR work-up and potential benefit in ICM patients undergoing CRT.
AB - Aim: To determine the feasibility and potential benefit of a full cardiac magnetic resonance (CMR) work-up for assessing the location of scarred myocardium and the region of latest contraction (LCR) in patients with ischaemic cardiomyopathy (ICM) undergoing cardiac resynchronisation therapy (CRT). Methods: In 30 patients, scar identification and contraction timing analysis was retrospectively performed on CMR images. Fluoroscopic left ventricular (LV) lead positions were scored with respect to scar location, and when placed outside scar, with respect to the LCR. The association between the lead position with respect to scar, the LCR and echocardiographic LV end-systolic volume (LVESV) reduction was subsequently evaluated. Results: The CMR work-up was feasible in all but one patient, in whom image quality was poor. Scar and contraction timing data were succesfully displayed on 36-segment cardiac bullseye plots. Patients with leads placed outside scar had larger LVESV reduction (−21 ± 21%, n = 19) compared to patients with leads within scar (1 ± 25%, n = 11), yet total scar burden was higher in the latter group. There was a trend towards larger LVESV reduction in patients with leads in the scar-free LCR, compared to leads situated in scar-free segments but not in the LCR (−34 ± 14% vs −15 ± 21%, p = 0.06). Conclusions: The degree of reverse remodelling was larger in patients with leads situated in a scar-free LCR. In patients with leads situated within scar there was a neutral effect on reverse remodelling, which can be caused both by higher scar burden or lead position. These findings demonstrate the feasibility of a CMR work-up and potential benefit in ICM patients undergoing CRT.
KW - Cardiac resynchronisation therapy
KW - Magnetic resonance imaging
KW - Treatment planning
UR - http://www.scopus.com/inward/record.url?scp=85078578401&partnerID=8YFLogxK
U2 - 10.1007/s12471-019-01360-6
DO - 10.1007/s12471-019-01360-6
M3 - Article
C2 - 31953775
AN - SCOPUS:85078578401
SN - 1568-5888
VL - 28
SP - 89
EP - 95
JO - Netherlands Heart Journal
JF - Netherlands Heart Journal
IS - 2
ER -